共 301 条
[31]
Haghdoost A(2008)Targeted sampling in drug abuse research: a review and case study Field Methods 20 155-98
[32]
Taherkhani R(2018)Establishing trust in HIV/HCV research among people who inject drugs (PWID): insights from empirical research PLoS One 13 e0208410-35
[33]
Farshadpour F(2013)Ethical issues in longitudinal studies: the case of ELSA-Brasil Rev Saude Publica 47 19-228
[34]
Razzaghi E(2016)The state of harm reduction in the Middle East and North Africa: a focus on Iran and Morocco Int J Drug Policy 31 184-6
[35]
Nassirimanesh B(2019)Drugs and drug policy in the Islamic Republic of Iran Middle East Briefs 119 2-44
[36]
Afshar P(2010)Barriers to HIV testing in Europe: a systematic review Eur J Pub Health 20 422-109
[37]
Ohiri K(2019)On the way to hepatitis C elimination in the Republic of Georgia—barriers and facilitators for people who inject drugs for engaging in the treatment program: a formative qualitative study PLoS One 14 e0216123-281
[38]
Claeson M(2016)Facilitators and barriers in HIV linkage to care interventions: a qualitative evidence review AIDS (London, England) 30 1639-309
[39]
Power R(2004)Homelessness and people with affective disorders and other mental illnesses J Appl Rehabil Couns 35 36-135
[40]
Alam-mehrjerdi Z(2014)The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations Lancet 384 1529-620